📖 A–Z Pharmacy Glossary & Knowledge Dictionary (64 Core Entries)
Authoritative student-friendly and advanced pharmacy dictionary by Tejas Nartam (Open Interactive Glossary on Homepage →).
- Absorption (Pharmacokinetics): Movement of a medicine from its site of administration (such as the gut or muscle) into the systemic bloodstream. Governed by passive lipophilic diffusion (Fick's law, pKa/Henderson-Hasselbalch), carrier-mediated SLC uptake (OCT1, OATP), and intestinal P-gp efflux.
- Active Pharmaceutical Ingredient (API) (Pharmaceutics & GMP): The biologically active chemical substance in a medicine that produces the intended therapeutic effect (e.g., Paracetamol in a tablet). Distinguished from excipients (diluents, binders, disintegrants, lubricants); regulated under Schedule M GMP and IP monograph purity standards.
- Adverse Drug Reaction (ADR) (Clinical Pharmacy & PvPI): An unwanted, harmful, or unintended response to a medicine occurring at normal doses used for prophylaxis, diagnosis, or therapy. Classified by Rawlings & Thompson into Type A (Augmented, dose-dependent) through Type F (Failure); assessed via WHO-UMC and Naranjo causality scales under PvPI (IPC Ghaziabad).
- Affinity (Pharmacology): How strongly a drug binds to its target receptor. Quantified inversely by the equilibrium dissociation constant Kd (concentration occupying 50% of receptors at equilibrium); distinct from intrinsic activity (alpha).
- Agonist (Full, Partial, Inverse) (Pharmacology): A drug that binds to a receptor and activates it to produce a biological response. Full agonists have intrinsic activity alpha = 1 (e.g., Morphine at mu-receptor); partial agonists have 0 < alpha < 1 (e.g., Buprenorphine) and act as competitive antagonists in the presence of a full agonist; inverse agonists (alpha < 0) stabilise the inactive receptor conformation.
- Alligation Alternate (Pharmaceutical Calculations): A rapid arithmetic grid method used to calculate the exact parts of a stronger and weaker solution needed to prepare a desired intermediate strength. Parts of Higher Strength (CH) = Desired (CD) - Lower (CL); Parts of Lower Strength (CL) = Higher (CH) - Desired (CD).
- Anaphylaxis (Clinical & Emergency Pharmacy): A severe, life-threatening Type I IgE-mediated systemic allergic reaction causing bronchospasm, laryngeal oedema, and hypotensive shock. Immediate first-line drug of choice is Intramuscular (IM) Adrenaline 1:1000 (1 mg/mL) into the anterolateral mid-thigh (0.3–0.5 mg in adults; 0.01 mg/kg in children).
- Antagonist (Competitive vs Non-Competitive) (Pharmacology): A drug that blocks a receptor (intrinsic activity = 0) and prevents agonists from activating it. Competitive antagonists (Atropine, Naloxone, Propranolol) cause a parallel rightward shift of the log DRC with unchanged Emax; non-competitive/irreversible antagonists (Phenoxybenzamine) depress Emax.
- Area Under the Curve (AUC) (Pharmacokinetics): Total systemic exposure to a drug over time, measured from a plasma concentration–time graph (mg·h/L). Calculated by the trapezoidal rule; AUC(0-inf) = (F × Dose) / Clearance (CL). Used to determine absolute and relative bioavailability.
- Aseptic Processing & Grade A (ISO 5) (Microbiology & Sterile Products): Handling sterile drugs and containers in a highly filtered Laminar Airflow (LAF) environment so zero microbial contamination enters. Grade A (ISO Class 5) laminar airflow benches maintain unidirectional air at 0.45 m/s ± 20% through HEPA filters (removing ≥99.97% of 0.3 micron particles; <1 CFU/m³).
- Beer–Lambert Law (Pharmaceutical Analysis): Law stating that light absorbance by a solution is directly proportional to concentration and path length (A = ε·b·c). Used in UV-Visible spectrophotometric assays (200–800 nm) with 1 cm quartz cuvettes; A = log10(I0/I).
- Bioavailability (F) (Pharmacokinetics): The fraction (%) and rate at which an administered dose of unchanged drug reaches the systemic circulation. Intravenous (IV) bioavailability is 100% (F = 1.0) by definition; oral bioavailability F = (AUC_oral / Dose_oral) / (AUC_IV / Dose_IV), reduced by incomplete absorption and gut/hepatic first-pass metabolism.
- Bioequivalence (BE) (Biopharmaceutics & Regulatory): Proof that two pharmaceutically equivalent products (e.g., a generic tablet and innovator brand) show comparable rate (Cmax) and extent (AUC) of absorption. Under CDSCO/FDA/EMA guidelines, the 90% confidence interval of the geometric mean ratio (Test/Reference) for Cmax and AUC must fall within 80.00% to 125.00%.
- Biopharmaceutics Classification System (BCS) (Biopharmaceutics): A 4-class scientific framework grouping drugs by aqueous solubility and intestinal permeability. Class I: High Sol / High Perm; Class II: Low Sol / High Perm (dissolution-limited); Class III: High Sol / Low Perm (permeability-limited); Class IV: Low Sol / Low Perm.
- Body Surface Area (BSA — Mosteller) (Clinical Calculations): Calculated surface area of the human body in square metres (m²), used for oncology, immunosuppressant, and paediatric dosing. Mosteller Formula: BSA (m²) = √([Height(cm) × Weight(kg)] / 3600). Standard adult reference BSA is 1.73 m².
- Capping & Lamination (Pharmaceutics (Tablets)): Tablet compression defects where the top/bottom crown separates (capping) or the tablet splits into horizontal layers (lamination). Caused by air entrapment in the die, excessive fines, overly dry granules, or excessive turret speed; corrected by pre-compression rollers, optimal moisture (2–4%), and binder adjustment.
- Clearance (CL) (Pharmacokinetics): The volume of plasma completely cleared of a drug per unit time (measured in L/h or mL/min). Total Systemic Clearance CL_tot = CL_renal + CL_hepatic + CL_other; governs steady-state concentration (Css = Dosing Rate / CL) and maintenance dosing.
- Cockcroft–Gault Equation (CrCl) (Clinical Calculations): Clinical formula estimating Creatinine Clearance (mL/min) from age, weight, sex, and serum creatinine to guide renal dose adjustment. CrCl (mL/min) = [(140 − Age) × Weight(kg)] / [72 × SCr(mg/dL)] × (0.85 if Female). Used across drug monographs for renal staging.
- Cold Chain (2 °C to 8 °C) (Microbiology & Pharmacy Practice): Temperature-controlled supply and storage chain (+2 °C to +8 °C in Ice-Lined Refrigerators) preserving vaccines, insulins, and biologicals. Monitored via Vaccine Vial Monitors (VVM) and stem thermometers; freeze-sensitive T-series vaccines (HepB, DPT, TT, Pentavalent) must never be frozen.
- Cytochrome P450 (CYP450) (Pharmacology & Metabolism): A superfamily of hepatic haem-containing enzymes (especially CYP3A4, CYP2D6, CYP2C9, CYP2C19) responsible for Phase I oxidation of most drugs. Enzyme inducers (Rifampicin, Phenytoin, Carbamazepine) accelerate substrate clearance and cause therapeutic failure; enzyme inhibitors (Azoles, Macrolides, Valproate) elevate plasma levels and cause toxicity.
- D-Value & Z-Value (Sterilisation & Microbiology): Sterilisation validation metrics measuring microbial heat resistance: D-value is time (min) to kill 90% (1 log) of spores; Z-value is temperature change (°C) altering D-value 10-fold. F0-value integrates lethality equivalent to minutes at 121 °C assuming Z = 10 °C; terminal sterilisation targets a Sterility Assurance Level (SAL) ≤ 10⁻⁶.
- Displacement Volume (Dry Powder Vials) (Injectable Calculations): The liquid volume occupied by dry antibiotic/drug powder itself when reconstituted in a vial. Diluent to Add (mL) = Target Final Reconstituted Volume (mL) − Powder Displacement Volume (mL). Essential for accurate neonatal/paediatric parenteral dosing.
- Drop Factor (Macrodrip vs Microdrip) (IV Infusion Calculations): Number of drops per millilitre (gtt/mL) delivered by an IV gravity giving set (15 or 20 gtt/mL for macrodrip; 60 gtt/mL for paediatric microdrip). Drip Rate (gtt/min) = [Volume (mL) × Drop Factor (gtt/mL)] / Time (minutes).
- Economic Order Quantity (EOQ) (Hospital Pharmacy & Store Management): Optimal order quantity in hospital inventory control that minimises total annual ordering cost plus carrying (holding) cost. EOQ = √[(2 × Annual Consumption × Cost per Order) / Annual Carrying Cost per Unit]. Used alongside ABC and VED inventory matrices.
- Enteric Coating (Pharmaceutics): An acid-resistant polymer barrier applied to oral tablets/pellets (e.g., Omeprazole, Pantoprazole, Enteric Aspirin) so they remain intact in stomach acid and dissolve in the intestine. Uses pH-dependent polymers with free carboxylic acid groups (Cellulose Acetate Phthalate [CAP], Eudragit L100/S100, HPMC Phthalate) that ionize above pH 5.5–6.8. Must never be crushed.
- First-Pass Metabolism (Presystemic Extraction) (Pharmacokinetics): Breakdown of an orally absorbed drug in the gut wall and liver (via the portal vein) before it reaches the systemic circulation. Drugs with high first-pass extraction (Nitroglycerin [1.4], Propranolol, Lignocaine, Morphine, Salbutamol) require higher oral doses than IV doses or alternative routes (sublingual, transdermal, inhalation).
- Flocculated vs Deflocculated Suspension (Physical Pharmaceutics): In a flocculated suspension, particles form loose clusters (flocs) that settle quickly but shake back up easily without forming a hard cake. Deflocculated particles settle slowly as individual units but pack tightly at the bottom into an irreversible hard cake (claying). Controlled flocculation uses electrolytes or polymers to adjust Zeta potential.
- Glomerular Filtration Rate (GFR) & eGFR (Renal Physiology & Clinical Pharmacy): Volume of fluid filtered from renal glomerular capillaries into Bowman's capsule per minute (~125 mL/min in healthy adults). Used to stage Chronic Kidney Disease (G1 ≥90 to G5 <15 mL/min/1.73m²) and gate nephrotoxic or renally cleared drugs (e.g., Metformin contraindicated when eGFR < 30 mL/min/1.73m²).
- Good Manufacturing Practices (Schedule M) (Pharmaceutical Jurisprudence & QA): Statutory quality assurance standards under Schedule M of the Drugs Rules, 1945 governing factory premises, equipment, documentation, and quality control. Revised Schedule M (notified Dec 2023) aligns Indian manufacturing standards with WHO-GMP, mandating Pharmaceutical Quality Systems (PQS), Quality Risk Management (QRM), HVAC cleanroom qualification, and computerised system validation.
- Half-Life (Elimination t½) (Pharmacokinetics): The time required for the plasma concentration (or total body amount) of a drug to decrease by 50%. For first-order kinetics, t½ = (0.693 × Vd) / CL = 0.693 / ke. Approximately 94–97% of steady state (Css) is reached — or eliminated after stopping — in 4 to 5 half-lives.
- Henderson–Hasselbalch Equation (Pharmaceutical Chemistry & Biopharmaceutics): Equation relating solution pH and drug pKa to the ratio of ionized (water-soluble) to unionized (lipid-soluble, membrane-permeable) drug. For weak acids: pH − pKa = log([A⁻]/[HA]); for weak bases: pH − pKa = log([B]/[BH⁺]). Explains gastric absorption of weak acids and urinary alkalinization (ion trapping) in salicylate/barbiturate overdose.
- Hydrophilic–Lipophilic Balance (HLB) (Physical Pharmaceutics): Griffin's 0–20 numerical scale measuring whether a surfactant is oil-loving (low HLB, W/O emulsifier) or water-loving (high HLB, O/W emulsifier). Spans (sorbitan esters) have low HLB (3–6 → W/O emulsions); Tweens (polysorbates) have high HLB (8–16 → O/W emulsions); solubilising agents have HLB 16–18.
- Ideal & Adjusted Body Weight (IBW / AdjBW) (Clinical Calculations): Height- and sex-based weight formulas (Devine) used to dose hydrophilic medicines (such as aminoglycosides or acyclovir) safely in obese patients. IBW (Male) = 50 + 2.3×(Height in inches − 60); IBW (Female) = 45.5 + 2.3×(Height in inches − 60). Adjusted Body Weight AdjBW = IBW + 0.4 × (Actual Weight − IBW).
- Indian Pharmacopoeia (IP) (Regulatory & Quality Control): The official book of standards for drugs manufactured, sold, and distributed in India, published by the Indian Pharmacopoeia Commission (IPC), Ghaziabad. Recognised under the Second Schedule to the Drugs and Cosmetics Act, 1940; 9th Edition (IP 2022) comprises 4 volumes containing general chapters, API/dosage-form monographs, biologics, and herbal standards.
- International Normalized Ratio (INR) (Clinical Laboratory & Anticoagulation): Standardised laboratory ratio of a patient's Prothrombin Time (PT) used to monitor oral Warfarin therapy. INR = (PT_patient / PT_normal)^ISI. Standard target INR for DVT/PE and Atrial Fibrillation is 2.0–3.0 (Mechanical Mitral Valve: 2.5–3.5). Supra-therapeutic INR carries major haemorrhage risk.
- Isotonicity & Sodium Chloride Equivalent (E-Value) (Pharmaceutical Calculations): Condition where an ophthalmic or parenteral solution has the same osmotic pressure as human tears and blood (equivalent to 0.9% w/v NaCl; ΔTf = 0.52 °C). The NaCl Equivalent (E-value) is the mass of NaCl (g) that produces the same osmotic effect as 1 g of a given drug: NaCl to add (g) = (0.009 × Volume_mL) − (Drug_g × E).
- Karl Fischer Titration (Aquametry) (Pharmaceutical Analysis): The standard pharmacopoeial titration method for determining trace moisture (water content) in APIs and lyophilized powders. Uses Karl Fischer reagent (Iodine, Sulphur Dioxide, Methanol, and Pyridine/Imidazole) where stoichiometric oxidation of SO2 by I2 requires water.
- Keller–Kiliani Test (Pharmacognosy): Specific chemical identification test for cardiac glycosides (Digitalis) detecting 2-deoxysugars (digitoxose). Drug extract in glacial acetic acid + trace FeCl3 underlayered with conc. H2SO4 produces a reddish-brown ring at the interface and bluish-green upper acetic acid layer.
- Laminar Airflow (LAF) & HEPA Filter (Sterile Compounding): An aseptic workbench using a High-Efficiency Particulate Air (HEPA) filter that traps ≥99.97% of particles ≥0.3 microns. Tested via DOP / PAO Challenge Test and anemometer velocity check (0.45 m/s ± 20%); provides ISO Class 5 (Grade A) aseptic compounding environment.
- Limulus Amebocyte Lysate (LAL) Test (Microbiology & Parenteral QC): In-vitro Bacterial Endotoxin Test (BET) using horseshoe crab amebocyte lysate to detect Gram-negative lipopolysaccharide (LPS) pyrogens in injectables. Performed via Gel-Clot, Turbidimetric, or Chromogenic methods; replaces the historical in-vivo Rabbit Pyrogen Test for most parenteral monographs.
- Loading Dose (LD) vs Maintenance Dose (MD) (Pharmacokinetics): A Loading Dose rapidly fills the body's Volume of Distribution (Vd) to achieve target plasma levels immediately; a Maintenance Dose replaces drug cleared over each dosing interval. LD = (Vd × Css) / F (governed by Vd); MD = (CL × Css × τ) / F (governed by Clearance CL).
- Look-Alike Sound-Alike (LASA) Medicines (Medication Safety & Pharmacy Practice): Medicines whose generic or brand names look or sound similar (e.g., Dopamine vs Dobutamine; Hydralazine vs Hydroxyzine; Vincristine vs Vinblastine), creating dispensing error risk. Mitigated via ISMP Tall-Man Lettering (e.g., DOBUTamine vs DOPamine), physical shelf segregation, auxiliary warning labels, and barcode verification.
- Lyophilisation (Freeze-Drying) (Pharmaceutics): Drying heat-sensitive injectables (antibiotics, biologics, vaccines) by freezing the solution and removing ice directly as vapour (sublimation) under vacuum below the triple point. Operates below the triple point of water (0.0098 °C, 4.58 mmHg / 611 Pa) in three stages: Freezing, Primary Drying (sublimation), and Secondary Drying (desorption).
- Michaelis–Menten Kinetics (Non-Linear PK) (Biochemistry & Pharmacokinetics): Saturable enzyme kinetics where reaction/elimination rate reaches a maximum ceiling (Vmax) at high substrate/drug concentrations. v = (Vmax × [S]) / (Km + [S]). Seen clinically with Phenytoin ([11.13]), where saturation of CYP2C9/2C19 shifts elimination from first-order to zero-order, causing steep toxicity from small dose increments.
- Milliequivalent (mEq) & Milliosmole (mOsm) (Pharmaceutical Calculations): mEq measures chemical combining power of an electrolyte ion based on mass, atomic/molecular weight, and valence; mOsm measures osmotic particle concentration. mEq = [Mass(mg) × Valence] / MW; mmol = Mass(mg) / MW; mOsm = mmol × number of dissociated particles (i).
- Minimum Inhibitory Concentration (MIC) (Microbiology & Antimicrobials): The lowest concentration (mcg/mL) of an antimicrobial agent that completely inhibits visible bacterial growth after 18–24 hours of incubation. Time-dependent antibiotics (Beta-lactams, Vancomycin) maximise efficacy by keeping free drug concentration above MIC (fT > MIC); concentration-dependent antibiotics (Aminoglycosides, Fluoroquinolones) maximise Cmax/MIC or AUC/MIC.
- Naranjo ADR Probability Scale (Pharmacovigilance (PvPI)): A 10-question weighted clinical questionnaire used to assess the likelihood that an adverse clinical event was caused by a specific drug. Total score categories: ≥9 = Definite ADR; 5–8 = Probable ADR; 1–4 = Possible ADR; ≤0 = Doubtful ADR.
- National List of Essential Medicines (NLEM) (Indian Regulatory & Public Health): Ministry of Health & Family Welfare list of priority medicines across Primary (P), Secondary (S), and Tertiary (T) healthcare levels in India. NLEM 2022 forms the basis for Schedule I of the Drugs (Prices Control) Order (DPCO), under which NPPA fixes statutory ceiling prices for scheduled formulations.
- Noyes–Whitney Dissolution Equation (Biopharmaceutics): Fundamental equation describing the rate at which a solid drug dissolves in a liquid medium: dC/dt = (D·A / h) × (Cs − C). D = diffusion coefficient, A = surface area (increased by micronisation), h = stagnant diffusion layer thickness (reduced by agitation), Cs = saturation solubility, C = bulk concentration (sink conditions when C < 0.15 Cs).
- Oral Rehydration Salts (WHO Low-Osmolarity ORS) (Clinical & Community Pharmacy): Life-saving glucose–electrolyte oral solution (245 mOsm/L) that uses intestinal SGLT1 sodium-glucose cotransport to rehydrate patients with acute diarrhoea. WHO Low-Osmolarity Formula per 1 Litre: Sodium Chloride 2.6 g (Na+ 75 mmol/L), Glucose anhydrous 13.5 g (75 mmol/L), Potassium Chloride 1.5 g (K+ 20 mmol/L), Trisodium Citrate dihydrate 2.9 g (Citrate 10 mmol/L) → Total Osmolarity = 245 mOsm/L. Paired with oral Zinc (20 mg/day for 14 days in children ≥6 months).
- Pharmacovigilance Programme of India (PvPI) (Clinical Pharmacy & Safety): India's national drug safety monitoring programme coordinated by the Indian Pharmacopoeia Commission (IPC), Ghaziabad. Collects Individual Case Safety Reports (ICSRs) from ADR Monitoring Centres (AMCs), healthcare professionals, and patients via ADR PvPI app/helpline and submits signals to CDSCO and WHO-UMC VigiBase.
- Potency (EC50) vs Maximal Efficacy (Emax) (Pharmacology): Potency is the dose/concentration required to produce 50% of a drug's maximal effect (EC50); Efficacy (Emax) is the highest therapeutic response the drug can achieve. On a semilogarithmic dose–response curve, position along the X-axis reflects potency (lower EC50 = higher potency), whereas the vertical plateau height reflects maximal efficacy (Emax).
- Prodrug (Medicinal Chemistry & Pharmacology): A pharmacologically inactive (or less active) compound that is converted inside the body by enzymes or chemical pH into the active drug. Designed to improve oral bioavailability (Enalapril, Valaciclovir), site-specific activation (Omeprazole in parietal canaliculi; Levodopa in CNS), or mask toxicity/taste (Chloramphenicol palmitate).
- Prescription Abbreviations (AC, PC, OD, BD, TID, QID, HS, SOS, PRN, STAT) (Community & Hospital Dispensing): Standard Latin-derived medical shorthand used on prescriptions to indicate dosing frequency and timing relative to meals or sleep. AC (ante cibum = before meals), PC (post cibum = after meals), OD (omni die = once daily), BD/BID (bis in die = twice daily), TID/TDS (three times daily), QID/QDS (four times daily), HS (hora somni = at bedtime), SOS / PRN (pro re nata = when required), STAT (statim = immediately).
- Ratio Strength (1:N) (Pharmaceutical Calculations): Concentration expression indicating 1 part of solute in N parts of solution (e.g., Adrenaline 1:1000 = 1 g in 1000 mL = 1 mg/mL = 0.1% w/v). Critical safety distinction: Adrenaline 1:1000 (1 mg/mL) is for IM anaphylaxis; Adrenaline 1:10,000 (0.1 mg/mL) is for IV cardiac arrest resuscitation.
- Schedule H & Schedule H1 (Drugs Rules, 1945) (Pharmaceutical Jurisprudence): Statutory Indian prescription-only drug schedules; Schedule H1 additionally requires a red-bordered Rx box and a 3-year dispensing register. Schedule H1 (46 drugs including 3rd/4th-gen cephalosporins, carbapenems, fluoroquinolones, anti-TB drugs, and Zolpidem/Tramadol) curbs over-the-counter antimicrobial misuse and AMR.
- Schedule X (Narcotic & Psychotropic Prescription Rules) (Pharmaceutical Jurisprudence): Strictest prescription schedule under the Drugs Rules, 1945 covering habit-forming psychotropic/narcotic drugs (e.g., Ketamine, Secobarbitone). Requires specific licence (Form 20F retail / Form 20G wholesale), NRx symbol in red on top-left of label, lock-and-key storage, and retention of duplicate prescription copy for 2 years.
- Sheiner–Tozer Equation (Corrected Phenytoin) (Clinical Pharmacokinetics & TDM): Formula correcting measured total serum Phenytoin concentration in patients with low serum albumin (hypoalbuminaemia) or renal failure. Phenytoin is ~90% bound to albumin; in hypoalbuminaemia, free (active) fraction rises. Corrected Phenytoin = Measured Phenytoin / [(0.2 × Albumin g/dL) + 0.1] (use 0.1 instead of 0.2 if CrCl < 10 mL/min). Target: 10–20 mcg/mL.
- Spurious, Adulterated & Misbranded Drugs (Sec 17, 17A, 17B) (Pharmaceutical Jurisprudence): Statutory definitions under the Drugs and Cosmetics Act 1940 for improperly labelled (Misbranded), contaminated/filthy (Adulterated), or counterfeit/substituted (Spurious) drugs. Sections 17 (Misbranded), 17A (Adulterated), and 17B (Spurious) for drugs; corresponding cosmetic sections are 17C, 17D, and 17E.
- Sterility Testing (FTM & SCDM Media) (Microbiology & Parenteral QC): Pharmacopoeial test verifying that a sterile batch is free from viable bacteria and fungi using Fluid Thioglycollate Medium (FTM) and Soybean–Casein Digest Medium (SCDM). FTM is incubated at 30–35 °C for 14 days (detects anaerobes and aerobes); SCDM is incubated at 20–25 °C for 14 days (detects fungi and aerobic bacteria).
- Therapeutic Drug Monitoring (TDM) (Clinical Pharmacy): Measuring serum drug concentrations at timed intervals (usually trough levels before the next dose) to individualise dosing of narrow-therapeutic-index drugs. Indicated for Phenytoin (10–20 mcg/mL), Digoxin (0.5–1.2 ng/mL in HF), Lithium (0.6–1.2 mEq/L), Vancomycin (AUC/MIC 400–600 or trough 10–20 mcg/mL), Aminoglycosides, and Cyclosporine/Tacrolimus.
- Therapeutic Index (TI) & Therapeutic Window (Pharmacology): Ratio of the dose causing toxicity in 50% of subjects (TD50) to the dose producing the desired effect in 50% (ED50): TI = TD50 / ED50. A high TI (e.g., Penicillins) indicates a wide safety margin; a low/narrow TI (Warfarin, Digoxin, Phenytoin, Lithium) requires strict dose titration and TDM.
- Volume of Distribution (Apparent Vd) (Pharmacokinetics): Theoretical fluid volume (L) that would be required to contain the total body amount of drug at the same concentration as measured in plasma: Vd = Dose / C0. Drugs heavily bound to plasma albumin (Warfarin, Heparin) have a small Vd (~4–10 L); lipophilic drugs sequestered in tissues (Chloroquine, Digoxin, Amiodarone) have a very large apparent Vd (>200–500 L) and are poorly removed by haemodialysis.
- Zero-Order vs First-Order Elimination Kinetics (Pharmacokinetics): In First-Order kinetics, a constant percentage of drug is eliminated per hour; in Zero-Order kinetics, enzymes are saturated and only a fixed milligram amount is eliminated per hour. First-order: Rate ∝ [C], half-life t½ = 0.693/ke is constant. Zero-order ('WPEA' — Warfarin high conc, Phenytoin, Ethanol, Aspirin high dose): Rate = k0 (constant), t½ increases as concentration rises.